CQK-70220-57688
2 vaccinations
11 coded responses
25 check-ins
11 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 077 / NJ
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Dose 1 — Moderna
-
2021-03-28
Registered in v-safe
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Joint stiffness — Feeling: Good · Site: Itching · DiarrheaFree text: My knee stiffness and mild pain have SUBSIDED SIGNIFICANTLY since the vaccine Will report any other changes as they occur.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-10
- 2021-04-17
-
2021-04-24
Dose 2 — Moderna
- 2021-04-24
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: GoodFree text: Since my 2nd dose, my blood glucose numbers have risen over 100 points without any change in diet. I take metformin and glipizide. I shall continue to report daily.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased, Pre-existing disease — Feeling: GoodFree text: Blood glucose levels over 100 points since 2nd dose. No change in diet or medication. Metformin er and glipizide erMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Extraordinary high blood glucose numbers since 2nd doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: GoodFree text: I continue to have higher blood glucose levels since 2nd dose. Will fast today to see results.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — day 7, dose 2MedDRA: Blood glucose increased — Feeling: GoodFree text: High blood glucose levels since 2nd doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-15
-
2021-05-22
Survey response — day 28, dose 2MedDRA: Blood glucose increased — Feeling: GoodFree text: My blood glucose levels continue to be elevated since my second dose. Roughly 75 to 100 points above previous level.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-29
Survey response — day 35, dose 2MedDRA: Blood glucose increased — Feeling: GoodFree text: My blood glucose levels continue to be elevated since dose 2. I have a cousin with type 1 who has had a similar experience. Has this been a problem?MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-05
Survey response — day 42, dose 2MedDRA: Blood pressure increased — Feeling: GoodFree text: Blood glucose levels continue to be elevated.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-24
Survey response — 3 months, dose 2MedDRA: Blood glucose increased, Glycosylated haemoglobin increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: As I reported several times, my blood glucose levels tests were averaging 70-100 points higher after my second shot. My A1C rose to 9.1 in my recent test. My physician had to increase my medication.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-24
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-02
- 2021-10-23
-
2022-04-24
Survey response — 12 months, dose 2MedDRA: Ageusia, Anosmia, COVID-19, Fatigue, Somnolence, Visual impairment — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had covid December 6, 2021. Had monoclonal infusion. Very mild symptoms. Loss of taste and smell for two months afterwards. Very tired. Sleeping 10+ hours per day. Slight vision issue.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Moderna | |
| 2 | 2021-04-24 | Moderna |
Call center
2 call center cases
2 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): My knee stiffness and mild pain have SUBSIDED SIGNIFICANTLY since the vaccine Will report any other changes as they occur.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Since my 2nd dose, my blood glucose numbers have risen over 100 points without any change in diet. I take metformin and glipizide. I shall continue to report daily.
Systemic reaction (other): Blood glucose levels over 100 points since 2nd dose. No change in diet or medication. Metformin er and glipizide er
Systemic reaction (other): Extraordinary high blood glucose numbers since 2nd dose
Systemic reaction (other): I continue to have higher blood glucose levels since 2nd dose. Will fast today to see results.
Release 8 — day 7, dose 2
Systemic reaction (other): High blood glucose levels since 2nd dose
Release 8 — day 28, dose 2
Symptoms: My blood glucose levels continue to be elevated since my second dose. Roughly 75 to 100 points above previous level.
Release 8 — day 35, dose 2
Symptoms: My blood glucose levels continue to be elevated since dose 2. I have a cousin with type 1 who has had a similar experience. Has this been a problem?
Release 8 — day 42, dose 2
Symptoms: Blood glucose levels continue to be elevated.
Release 9 — 3 months, dose 2
Symptoms: As I reported several times, my blood glucose levels tests were averaging 70-100 points higher after my second shot. My A1C rose to 9.1 in my recent test. My physician had to increase my medication.
Release 11 — 12 months, dose 2
Symptoms: Had covid December 6, 2021. Had monoclonal infusion. Very mild symptoms. Loss of taste and smell for two months afterwards. Very tired. Sleeping 10+ hours per day. Slight vision issue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Blood glucose increased | ✓ | ✓ | ✓ |
| SD | Blood pressure increased | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Glycosylated haemoglobin increased | ✓ | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Joint stiffness | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release